• Over 25 years’ experience in Logistics, Supply Chain, Procurement and Demand Planning areas.
  Solid knowledge and experience in the whole S&OP process and its KPI´s inter-relationships with stakeholders
• Demand Planning process management - pre-S&OP, with Sales, Marketing, Trade Marketing, Industrial Planning and Finance and customized tool design for such process
• Management skills: experience with multidisciplinary and international teams (Brazil / Latin America / US).
• Experience in S&OP, 3PL and Supply Chain Organization projects' implementation
• Strong experience with Pharmaceutical and Consumer companies and Brazilian distribution model / 3PL contracts
• Solid team management skills, as well as Customer Service relationship and management
• Teacher for major Post Graduation Schools - Demand Planning and Procurement/Negotiation areas

CSCP & CPIM APICS. Logistics & Supply Chain driven strategy. Distribution & Logistics, Demand Planning, S&OP, Procurement and Export experiences, focusing on Business necessities through effective leadership.

Working as External Manufacturing Operations Manager Latin America at Bayer, in charge for external partners for CHC Division. Previously as Relationship Associated Director at Merck , Logistics Manager at Takeda/Nycomed Pharma, focusing on demand management, planning and distribution activities. Also has worked as Pfizer´s Logistic Manager and EFD´s Supply Chain Manager. Souza Cruz´s Procurement Manager and Rhodia's Logistic Supervisor.

Specialties: Logistics, Supply Chain, Materials, Procurement , Services, Negotiation, 3PL contracts, S&OP, Demand Planning

Amanda Briceno is an experienced clinical supply professional with over 10 years in clinical research and supply chain operations. Originally from Venezuela, now based in Italy. She currently serves as Clinical Supply Manager and Head of the Patient Centricity Unit at Chiesi Farmaceutici, where she leads initiatives to design and deliver patient-focused clinical supply solutions that improve trial compliance and enhance the experience of both patients and site staff.

Her career began as a Clinical Research Associate at IQVIA, where she gained extensive experience in global trial monitoring and operations. Since joining Chiesi, Amanda has held positions of increasing responsibility within the Clinical Supply department, before assuming her current leadership role.

Amanda holds a Master’s degree in Drug Biotechnology from the Università degli Studi di Milano and a Bachelor’s degree in Medical Biotechnology. Amanda brings a strong blend of technical knowledge and operational leadership. Passionate about innovation in clinical supplies, she is dedicated to advancing more accessible, patient-centric clinical trials.

Ana-Zeralda Canals Hamann is an Associate Director in Clinical Trial Supplies & CMC Project Leader at Debiopharm International SA based in Lausanne, Switzerland. A clinical supply chain leader with over 15 years of experience, she specializes in CMC, logistics, and operations within complex, international biopharmaceutical environments.

She has a proven record of building global clinical supply strategies across multiple therapeutic areas, including oncology and rare diseases. Her operational expertise spans GxP/GMP/GDP compliance, digitalization, sustainability, and Lean transformation. She is actively involved in the industry as a Committee Member and former Chair of the European Global Clinical Supplies Group (GCSG) and serves on the Research Ethics Committee at Queen Mary University of London.

Kamal is a trained Chemist who decided to pursue a career in supply chain management and quality. In this role, he was tasked to supervise commercial and clinical trial products. Kamal has worked in the pharmaceutical and device industries for over 15 years in different size organisations ranging from large multinational to small virtual companies. He is currently leading a global team at Galderma to develop an integrated clinical supply chain organisation within the company.

Dr Katriona Brooksbank holds a BSc (Hons) in Genetics (Immunology) and a PhD in Medicine and Therapeutics from the University of Aberdeen.

With experience spanning academia, industry, and the health service both in the UK and internationally, Katriona has specialised in the ethical design and delivery of observational health research and clinical trials, as well as innovation and technology evidence generation in healthcare. To complement her postdoctoral work in novel therapeutics—including digital solutions and AI as a medical device—she completed a Master of Laws in Medical Law and Ethics.

Currently, Katriona is the R&I Innovation Lead for WosIH (core CSO funded), supporting innovation across Health Boards in the West of Scotland and collaborating closely with colleagues in the North and East of Scotland. She is Co-Chair of the AI Governance Group, a member of the National Steering Committee for AI deployment, and Chair of the Health Research Authority Research Ethics Committee (WoSREC1).

As Intellectual Property Officer at NHSGGC, she supports benefit sharing with partners. Katriona is also an Honorary Associate Professor at the University of Glasgow, teaching and directing the MSc in MedTech Innovation and leading courses on ethics, regulation, and governance.

Arnaud Dourlens is an Arts et Métiers engineer, he began his industrial career in the FMCG sector where he held growing responsibilities. Then he joined the LVMH group where he reorganized new product launches and industrial investments in the Make-up segment in order to adapt to the need for innovation and time to market, thus providing a competitive advantage. He then managed the entire portfolio of industrial launches and investments in Perfumes, Skincare and Make-up for Parfums Christian Dior Group.

During his career Arnaud held a wide variety of industrial roles. He joined Sanofi in 2017 as Production Director of a major solid oral form production site (>2.5 billion € turnover). He has been a key player in the development of the continuous improvement mindset and in the transformation of the site through IT projects, investments and activity growth following the acquisition of Boehringer Ingelheim consumer healthcare portfolio.

Since the beginning of 2020, he’s been the global head of Sanofi Clinical Supply Chain Operations, managing worldwide clinical supply teams involved in more than 300 clinical studies.

20y+ experience within pharmaceutical industry and specially within clinical supply chain, Digital development, and innovation.

Career started as a biochemist engineer, Landry has moved progressively to drug manufacturing process development, GMP production, comparator supply & material flow management and then innovation and technology for clinical supplies.

Key drivers of his career are continuous improvement, factual based decision and valuable innovation implementation.

A hands-on engineer with plenty of industry and R&D experience, who likes to experiment with new technologies, design and deploy novel solutions, and inspire the new generations of engineers and digital innovators.

A firm believer in the use of advanced technology and artificial intelligence to increase our quality of life, and to build a better society.

A promoter of best practices to ensure technologies are useful, safe and trustworthy.

You will find Dejanira leading teams of engineers and supply chain experts, sharing a vision of future technologies and digital capabilities with global leaders and future engineers, or bouncing ideas off other experts.

Martina holds a Master's in Pharmaceutical Science from Karl-Franzens-University Graz, Austria. Her certifications include Lean Six Sigma Green Belt, St. Gallen Management Institute Business Strategy, and the London Business School programs re. Accelerated Development as well as the Innovation Through Design Thinking.

Over her 25-year career, she's taken on multifaceted roles at Fresenius Kabi, Roche, and MSD, spanning divisions across Research, Manufacturing, Commercial and Global Support Functions. She developed drug products to market and pioneered a novel single-use auto-injection device platform for sterile dosage forms. Beyond product development, Martina has been leading business process streamlining, strategic development, and organizational integration. Her achievements include establishing the global MSD Innovation and Development Hub in Zurich, founding the global MSD Center of Excellence for Comparator Blinding, innovating an early phase biologics supply chain, amplifying Enterprise Strategy Office projects as a Design Thinking Facilitator and enhancing the Global Market Access forecasting methodology. Currently she is creating innovative solutions for clinical supply operations, clinical sites, and leading digitalization as well as people innovation endeavors; she is leading the MSD Digital Display Labeling (DDL) project as well as co-leading the cross-industry DDL Community of Practice.

Irena Seredina’ background is medicine, economics and management. She holds an MD, honors diploma and a MSc in Health Economics. During her medical practice,  Irena  worked in clinical research as a researcher and an investigator. The results of her research have been published in a number of articles and she is a recognized speaker at several industry forums and international conferences.  Irena worked at Amgen, and then joined S-Clinica in 2004. Now, as  Executive Director Irena gives direction for the product strategy and customer relationships.

Jas started his career in the 90s, as a data manager within clinical trials when these were done predominantly on paper - and has over the years seen the industry change and evolve.

He has a degree in Applied Physics, and has worked over the last 25 years within eClinical technologies and solutions, with global responsibilities in project management, solutions consulting and sales. Jas's role within S-CLINICA is to bring new business, and build strategic relationships with customers.

As Product Manager at TSS, Hanna Söderström is driving the strategic development of the clinical trials software platform, which is used by leading pharmaceutical companies in delivering life-saving medicine to patients faster. In productive partnerships with big pharma, Hanna has been driving change in the clinical supply chain by delivering automation and digitalization. Hanna’s mission is to deliver a product shortening clinical study timelines, increasing patient safety and serving TSS clients to become sponsors of choice.

Tine Bülow is an established Supply Chain Project Manager with over 12 years of experience in clinical IT systems. She brings extensive expertise in integrating clinical technologies to optimize trial operations, with a strong focus on temperature management and data integrity throughout the temperature deviation process. Her background includes 8 years working with Interactive Response Technology (IRT) systems and 4 years dedicated to advanced temperature control solutions.

Tine’s work centers on safeguarding both product and data integrity across the entire supply chain—from packaging and shipment to storage at clinical sites—ensuring that patients receive safe and effective investigational products under optimal conditions. Passionate about reliability and compliance, she is committed to driving smarter, innovative solutions that strengthen quality, trustworthiness, and integrity in clinical trial delivery—ultimately protecting patient safety and improving trial outcomes.

Louise Oliver is CRO Strategic Operations Manager at Almac, where she leads a global team responsible for building strategic partnerships with CRO clients and driving best practices in study operationalisation. Based at Almac’s global headquarters in Northern Ireland, Louise brings more than 25 years of experience across clinical trials, having progressed from Clinical Research Associate to Project Manager and ultimately Head of Clinical Operations for an early‑phase CRO.

She holds a PhD in Biomedical Engineering from Ulster University, with advanced studies in vaccine development at the University of Oxford and in pharmaceutical medicine at King’s College London.

A champion of balanced GCP–GMP delivery, Louise has implemented a global engagement framework and optimised clinical supply chains to accelerate start‑up and improve delivery performance.

Since March 2024, Frank Jäger has been leading the global business of CCL Clinical worldwide as Commercial Director worldwide, overseeing collaboration with the research-based pharmaceutical industry.

An economist by training, he has been part of the management team at CCL Faubel GmbH since 2014, where he is responsible for sales, marketing, label design, product development, and smart labels.

As a long-standing member of the International Society for Pharmaceutical Engineering (ISPE), he has delivered numerous presentations at trade shows and conferences, addressing specific challenges

related to the labeling and packaging of active ingredients and therapies. In 2024, he was appointed to the ISPE Steering Committee as a special honor.

Mark Berry is an expert in the clinical trial supply chain, with more than 15 years’ experience as a supply chain and project manager at Almac Group and Cenduit, now IQVIA Technologies. He works with closely with sponsors to implement randomization and trial supply technologies that advance drug accountability and ensure a reliable, lean, and sustainable supply chain. Mark holds a BSc in Mathematics from Queen’s University Belfast.

Brian joined, the then WestRock, in 2018 as Vice President Global Adherence & Clinicals - the business unit focused on providing Adherence focused, patient centric and Child Resistant Senior Friendly (CR-SF) packaging & service solutions to the Pharmaceutical, Biotech & Clinical Trial industries.

Having majored in marketing, business studies and finance Brians key expertise has been developing packaging solutions supplied to these key markets. Holding a wide range of increasingly elevated positions within companies such as Cardinal Health, Catalent and across several other packaging entities, Brian has gained invaluable insights and a thorough understanding of the demanding requirements, operating systems and ethos of the various market sectors that Smurfit Westrock support today.

Within the last number of years Brian's focus, together with his globally based team, has been to strategically develop a bespoke, best in class global supply infrastructure within the Smurfit Westrock specialized field of Adherence, Clinical Trial and SMART digital & electronic platforms. These cutting-edge solutions encompass electronically enhanced SMART measure and monitor packaging solutions, such as Cere®Pak, together with developing the vision and capabilities of Cere®Screen Digital Display Labels within the Clinical Trial Supplies arena..

• Expert in information management and large language model applications
• Manager, Digital Transformation in Supply Chain Management (Pharma)
• Over 30 years of experience in a global industrial environment
• Extensive international track record across the USA, Vietnam, China, and Europe
• Recipient of the 2017 Supply Chain Breakthrough of the Year Award (Crop area)
• Bicultural: French–German background
• Conference speaker on digital transformation, artificial intelligence, and innovation methods

Tom has worked in the life sciences industry since 1997, with the first 10 years spent as a pharmaceutical representative and marketing product manager for Bertek, Merck and GSK.

Tom joined Valeris in 2008, created the RxStudy Card offering in 2009 and since then has been focused on changing the paradigm of the traditional clinical trial supply process to one of greater efficiency.

As Clinical Supply Chain Solutions Consultant, he currently assists Suvoda with his knowledge in various areas of clinical trial supply management. Prior to Suvoda, he co-founded the clinical trial supplies department at Grünenthal GmbH and served as its Associate Director for 10 years. While at Grünenthal, he developed operational processes and championed risk management procedures to establish the company as a clear market leader in the area of clinical supply chain. More recently, he served as Senior Investigational Medicinal Product Manager at BioNTech SE, where he streamlined data processing operations in the clinical supply chain for personalized oncology therapies. He is an innovative expert in the field of IRT, temperature excursion management, and direct-to-patient logistics. 

Mergime Behrami is a Senior Manager in Sales at Thermo Fisher Scientific, leading engagement with biotech customers across mainland Europe. Since joining the company in 2016, Mergime has built a career spanning project management and business development, with a strong focus on delivering consultative solutions to biotech partners. Before Thermo Fisher, Mergime gained experience in early-phase clinical trial management at Parexel and in quality functions at Celgene.

Joanna has worked in the IRT industry for over 20 years in various roles, gaining extensive experience in bridging the gap between technical capabilities and client needs. For the past nine years, she has specialized as a Solutions Consultant, helping clients design and implement tailored IRT solutions to streamline clinical trial operations.

Daniela leads Suvoda’s global eClinical Solutions Consulting team and is based in the Barcelona office. She works closely with clients and prospects, delivering presentations and demonstrations while serving as a subject matter expert on Suvoda’s solutions.  

Daniela joined Suvoda seven years ago in the Services Delivery organization, where she worked in project management and gained deep, hands-on experience in IRT solution delivery. This background enables her to bring strong practical insight and real-world expertise to every consulting engagement. 

Marine has been a Clinical Supply Optimization Specialist (CSOS) at Sanofi since July 2022. In this position, she focuses on identifying optimization levers to be tested at the study level, challenging trial designs to improve efficiency. She defines Interactive Response Technology (IRT) strategies for individual studies and leads efforts to standardize new features that enhance IRT usage and strengthen process robustness.

Marine developed IRT expertise through her previous role as a Drug Manager, during which she implemented multiple IRT solutions across a wide range of clinical studies, including complex trial designs. This hands-on experience provided her with deep technical knowledge and practical insights, which she now leverages to optimize clinical supply operations at Sanofi.

Marion has served as IRT (Interactive Response Technology) Governance Leader at Sanofi since March 2023. In this strategic role, she oversees partnerships with multiple IRT vendors and ensures the optimal allocation of clinical studies based on key performance indicators (KPIs) that are monitored monthly.

Her IRT expertise is built on seven years of experience as a Drug Manager (2016–2023), during which she led the implementation of multiple IRT systems across a wide range of clinical studies.

Marion has extensive experience supporting post-acquisition trial continuity and has collaborated closely with IRT vendors to shape Sanofi’s technology partnership strategy. She has been instrumental in the expansion and transformation of the IRT vendor ecosystem.

Silke has over 25 years’ experience in the pharmaceutical sector and has been with Merck healthcare KGaA, Darmstadt, Germany — Clinical Trial Supplies since 2005. She leads Planning, Systems & Innovations, overseeing interactive response technologies (IRT), material demand planning and optimization of supply activities. Silke drives digitalization projects such as IMP temperature tracking and champions patient‑centric initiatives including packaging design and adherence monitoring. Combining scientific insight with operational leadership, she focuses on improving sustainability, reliability and patient experience across global clinical supply chains.

Silke holds a Diploma in Biology from University of Würzburg, Germany.

With over two decades of experience at the intersection of clinical systems and operational strategy, Everett is a veteran in global drug development and eClinical technology. Currently a Global Team Lead at Medidata Solutions, he specializes in Randomization and Trial Supply Management (RTSM). He is particularly passionate about optimizing RTSM operational dashboards with a supply focus to accelerate actionable insights and is dedicated to simplifying clinical data workflows through automated data integration and transformation.

Vanesa is a solution consultant for 3DS-Medidata with a product focus on Rave RTSM. With over 10 years experience in multiple different roles across the clinical trial space, she enjoys using her combined experience to help define technology approaches to solve complex operational challenges.

Martin is a Strategic Account Manager at N-SIDE with 10+ years of experience in the industry, combining planning experience both on the commercial and clinical sides of the supply chain.

Clinical Supply Chain Specialist at mAbxience (Madrid, Spain), Master in Neuroscience.

In this role, she is working within the Clinical Team as well as different international service providers to support the execution of the operational flow, ensuring streamlined drug supply throughout the clinical studies delivering on time, within budget, and of high quality in compliance with ICH/GCP, Regulatory Authorities regulations/guidelines, and applicable Standard Operating Procedures.

For almost a year in mAbxience, in conjunction with her previous role in Immutep since 2019, she brings a wealth of experience in clinical trial supply management, vendor oversight and operational excellence.

Her expertise covers supporting clinical study teams from start up to completion, working with CROs, CMOs and several logistic stakeholders in a very international environment (10 years abroad in between Germany and France), ensuring meeting program timelines with the highest standards of quality and efficiency.

Sonnika Lamont, MRes, is a Clinical Trials Senior Analyst at GlobalData, where her primary responsibilities include the review and update of clinical trial information presented on GlobalData’s Trials Intelligence Platform, the production of analytical reports and insights, testing database releases, and providing comprehensive conference coverage. She has a firm understanding of all aspects of clinical research, and the drug development process. Prior to joining GlobalData, Sonnika worked as a Clinical Trials Research Assistant at University College London’s Cancer Institute. Sonnika holds a Master of Research in Drug Design with a concentration in rare diseases from University College London, and a Bachelor of Science in Biochemistry from Nottingham Trent University.

Gemma Lofts is an accomplished Clinical Supply Chain professional with over 12 years of experience working in oncology, respiratory, cell and gene and controlled drugs. Gemma is currently the Director of Clinical Supply Chain at Bicycle Therapeutics, where she has set up end-to-end processes to support the expansion of their oncology platform from phase 1 into global phase 2/3 registrational trials. As a small biotech moving to mid-size with a fully outsourced model, this included the selection and set up of new vendors and procedures to ensure best practice and compliance.

Gunter Van Hoof is the Vice President of Global Clinical Trial Distribution at
Marken, UPS Healthcare Precision Logistics, where he leads worldwide operations for the
storage and distribution of temperature-sensitive investigational medicinal
products (IMPs) and advanced therapies. With over 25 years of experience in
the clinical trials industry, Gunter has developed deep expertise in global
supply chain management, cold-chain logistics, and operational excellence
for complex studies, including cell and gene therapies. He oversees Marken’s global depot network, ensuring compliance with GDP and GxP standards across all regions. Gunter is passionate about driving innovation in clinical trial distribution to support life-saving therapies and improve patient outcomes worldwide.

Amaury Jeandrain has a Master’s Degree in Business Engineering with a specialization in supply chain optimization. He joined Clinigen in 2015, then N-SIDE in 2016 where he last  held the position of VP of Strategy for clinical supply solutions.

Over the past decade, his objective has been to make clinical trial supply chains more efficient by redefining CTS strategies and driving measurable performance improvements. His expertise also includes forecasting, planning, waste reduction, and shortage risk mitigation.

Since 2024, while accompanying his wife on humanitarian missions abroad (Niger, then Colombia), Amaury has continued his work as a CTS advisor and trainer, partnering with pharmaceutical companies worldwide to enhance clinical supply performance.

Bernd Steffens is currently IU Sustainability Lead Clinical Trials, at Boehringer Ingelheim, based in Biberach, Germany. His ambition is to contribute to the understanding of environmental impact aspects in clinical trials and their decarbonization. Before that he was for about 30 years Head of the Global Clinical Trial Supplies Unit or related functions in the same company, with focus on Supply Chain Management in general, outsourcing strategies, smart global distribution strategies and digitalization initiatives.

He is chemist by profession with diploma and PhD from the Ruhr-Universitaet Bochum and started in industry with process development in API manufacture.

Michael Hoefling is currently Head of Digitalization and Automation, at Boehringer Ingelheim, based in Biberach, Germany.

He aims at advancing digital transformation and automation across drug product development for NCEs including clinical manufacturing. His work focuses on implementing innovative, robust, and state-of-the-art information technologies that comply with regulatory requirements and enhance efficiency, quality, and sustainability.

Michael is an IEEE Senior Member and holds a strong academic background in computer science, including B.Sc. and M.Sc. degrees from Umeå University (Sweden), a Diplom-Informatiker degree from the University of Wuerzburg (Germany), and a Ph.D. from the University of Tuebingen (Germany).

Stefan Seebacher is the IT program lead in the Clinical Trial Supply Program at Boehringer Ingelheim and is based in Biberach, Germany. In his role, he implements and supports data‑driven processes and solutions, working closely with cross‑functional teams to enhance reliability, efficiency, and strategic value within the clinical trial supply IT landscape.

Stefan has a strong academic background in information systems, holding a PhD from Karlsruhe Institute of Technology (KIT).

PhD in Natural Sciences

20 years in the Pharmaceutical Industry: CRO and Pharma

5 years Sales for Temp and Condition Monitoring solutions

Strong Science and Clinical Trials Background

Meets and exceeds clients expectations, consultant and solution provider

Linda Schwär has over 8 years of experience in the measurement industry, where she has held various marketing and sales roles with a focus on cold chain solutions for the food and pharmaceutical sectors. Currently, she serves as Head of Sales, Life Sciences EMEA for Sensitech, a part of Carrier’s Climate Solutions Transportation business.

Zayheda Khan was appointed Chief Commercial Officer in December 2022 and UK Managing Director in October 2024.

She has more than 20 years experience in a variety of roles within the clinical trial sectors including preclinical, clinical, proposal and budgeting, procurement and programme management.

Zayheda oversees the Marketing, Sales/KAM, Commercial Operations, Procurement and Project Management functions with the aim of assessing customer needs and providing cost-effective tailor-made solutions.

She is also responsible for the commercial data analysis for accurate forecasts and opportunity pipeline management and her organisation is driven to develop customer partnerships and drive forward the success of the commercial projects in an ever-changing clinical trial landscape.

Zayheda has a Bachelor’s Degree from the University of Central Lancashire and Master and PhD Degrees in Pharmacology from The University of Bradford.

Karine Gradziel is the Chief Commercial Officer at CRYOPDP and Head of Global Business Development and Customer Solutions for Clinical Logistics at DHL. She brings more than 25 years of international logistics experience, dedicated to the life sciences and healthcare sector. Karine leads global commercial strategy across clinical trials and advanced therapies logistics, with a focus on go-to-market strategy and solution design for complex logistics needs.

Marco Flapper is Regional Customer and Business Development Manager for Life Science and Healthcare at DHL Express. With nearly 19 years at DHL and a focus on life sciences since 2019, he supports customers running time-critical healthcare and clinical shipments across Europe. He is known for staying close to what teams need day to day, then turning it into practical program set-ups.

Amanda’s career in clinical trial supply management has spanned over 20 years now. She got her start at a wholesaler handling named-patient import, hospital supply and specializing in global comparator sourcing. She then moved on to a CRO as the single-point of contact for drug, ancillary, and sample management for phase II-III trials with various indications and drug types, including cell therapies. In 2021 she made the jump from the service-provider to the sponsor side of things as a consultant, and is now employed at Immutep GmbH.